Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Randomized Phase III of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas

Disease Sites: Not Available

Phase: III

Investigator: Davis, Elizabeth

NCTID: NCT06422806

Protocol No: VICC-NTSAR24139

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

Multiple Cancer Types

Disease Sites: Head/Neck, Phase I

Phase: I

Investigator: Rosenthal, Eben

NCTID:

Protocol No: VICCHNP24602

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form